Patents by Inventor Zbigniew Pietrzkowski

Zbigniew Pietrzkowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944610
    Abstract: Compositions, methods, and uses are contemplated in which a betalain-containing preparation is administered to a mammal to enhance athletic performance. Most preferably, the preparations are substantially nitrate free and acutely and transiently increase hematocrit, erythropoietin, adrenalin, and beta endorphin, while reducing serum lactate, serum lactate dehydrogenase, heart rate and a rate of perceived exertion.
    Type: Grant
    Filed: August 16, 2022
    Date of Patent: April 2, 2024
    Assignee: VDF FutureCeuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20230398138
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Application
    Filed: August 24, 2023
    Publication date: December 14, 2023
    Applicant: VDF Futureceuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 11771713
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Grant
    Filed: May 6, 2021
    Date of Patent: October 3, 2023
    Assignee: VDF FutureCeuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20220387409
    Abstract: Compositions, methods, and uses are contemplated in which a betalain-containing preparation is administered to a mammal to enhance athletic performance. Most preferably, the preparations are substantially nitrate free and acutely and transiently increase hematocrit, erythropoietin, adrenalin, and beta endorphin, while reducing serum lactate, serum lactate dehydrogenase, heart rate and a rate of perceived exertion.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 8, 2022
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 11471500
    Abstract: Compositions and methods are presented that substantially increase levels of BDNF in blood, and even more pronouncedly exosomal BDNF levels. Suitable compositions include whole coffee fruit extracts and powders that are orally administered at relatively low dosages.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: October 18, 2022
    Assignee: VDF FutureCeuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 11446284
    Abstract: Compositions, methods, and uses are contemplated in which a betalain-containing preparation is administered to a mammal to enhance athletic performance. Most preferably, the preparations are substantially nitrate free and acutely and transiently increase hematocrit, erythropoietin, adrenalin, and beta endorphin, while reducing serum lactate, serum lactate dehydrogenase, heart rate and a rate of perceived exertion.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: September 20, 2022
    Assignee: VDF FutureCeuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20210338762
    Abstract: Compositions and methods are presented that substantially increase levels of BDNF in blood, and even more pronouncedly exosomal BDNF levels. Suitable compositions include whole coffee fruit extracts and powders that are orally administered at relatively low dosages.
    Type: Application
    Filed: July 15, 2021
    Publication date: November 4, 2021
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20210260088
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Application
    Filed: May 6, 2021
    Publication date: August 26, 2021
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 11026962
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: June 8, 2021
    Assignee: VDF Futureceuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20200113922
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Application
    Filed: December 12, 2019
    Publication date: April 16, 2020
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 10543224
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: January 28, 2020
    Assignee: VDF Futureceuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20190060387
    Abstract: Compositions and methods are presented that substantially increase levels of BDNF in blood, and even more pronouncedly exosomal BDNF levels. Suitable compositions include whole coffee fruit extracts and powders that are orally administered at relatively low dosages.
    Type: Application
    Filed: October 25, 2018
    Publication date: February 28, 2019
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 10125161
    Abstract: Solid, free-flowing, and substantially completely dissolvable preparations with high betalain content are presented. Most typically, the betalain profile of the preparations is near natural and includes betalains in an amount of between 10-40 wt %. As the preparations of the inventive subject matter maintain chemical stability and flowability over extended periods of time, it should be noted that the betalain preparations are now amenable to compounding in small and measured quantities. Furthermore, new biological activities of betalains are shown, and especially include significant induction of SIRT and reduction of serum triglyceride.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: November 13, 2018
    Inventors: Zbigniew Pietrzkowski, Wayne Carl Thresher
  • Publication number: 20180296544
    Abstract: Compositions, methods, and uses are contemplated in which a betalain-containing preparation is administered to a mammal to enhance athletic performance. Most preferably, the preparations are substantially nitrate free and acutely and transiently increase hematocrit, erythropoietin, adrenalin, and beta endorphin, while reducing serum lactate, serum lactate dehydrogenase, heart rate and a rate of perceived exertion.
    Type: Application
    Filed: May 27, 2016
    Publication date: October 18, 2018
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20170216331
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Application
    Filed: April 14, 2017
    Publication date: August 3, 2017
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 9636371
    Abstract: Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: May 2, 2017
    Assignee: VDF Futureceuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 9327005
    Abstract: Compositions and methods for dietary supplements that contain a cold-water extract of humic shale and/or an extract of the apple fruit or skin of the apple fruit that is/are effective to modulate in vivo cytokines, oxygen consumption rate, extracellular acidification rate, and ATP production.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: May 3, 2016
    Assignee: VDF Futureceuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Patent number: 9271994
    Abstract: Contemplated compositions and methods are drawn to use of various boron-containing compounds to temporarily and transiently increase endogenous blood calcitriol concentration. The boron-containing compound is preferably a carbohydrate-boron complex having sufficient stability to achieve measurable quantities of the complex in blood upon oral administration of the complex.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: March 1, 2016
    Assignee: VDF Futureceuticals, Inc.
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20160038557
    Abstract: Compositions and methods are presented that substantially increase levels of BDNF in blood, and even more pronouncedly exosomal BDNF levels. Suitable compositions include whole coffee fruit extracts and powders or procyanidin-enriched preparations that are orally administered at relatively low dosages. The augmentation of the levels of natural stimulating factor takes place in cerebral circulation.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 11, 2016
    Inventor: Zbigniew Pietrzkowski
  • Publication number: 20150322106
    Abstract: Solid, free-flowing, and substantially completely dissolvable preparations with high betalain content are presented. Most typically, the betalain profile of the preparations is near natural and includes betalains in an amount of between 10-40 wt %. As the preparations of the inventive subject matter maintain chemical stability and flowability over extended periods of time, it should be noted that the betalain preparations are now amenable to compounding in small and measured quantities. Furthermore, new biological activities of betalains are shown, and especially include significant induction of SIRT and reduction of serum triglyceride.
    Type: Application
    Filed: July 2, 2015
    Publication date: November 12, 2015
    Inventors: Zbigniew Pietrzkowski, Wayne Carl Thresher